Testing a Primary and a Secondary Endpoint in a Group Sequential Design-Reference-Cited by-同舟云学术

Testing a Primary and a Secondary Endpoint in a Group Sequential Design

Published:2010-03-11 Issue:4 Volume:66 Page:1174-1184
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:

Author:

Tamhane Ajit C.,Mehta Cyrus R.,Liu Lingyun

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1541-0420.2010.01402.x/fullpdf

Reference15 articles.

1. P-value maximized over a confidence set for the nuisance parameter;Berger;Journal of the American Statistical Association,1994

2. Gatekeeping procedures with clinical trial applications;Dmitrienko;Journal of Pharmaceutical Statistics,2007

3. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials;Hung;Journal of Biopharmaceutical Statistics,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Familywise error for multiple time‐to‐event endpoints in a group sequential design;Statistics in Medicine;2024-06-09

2. Optimal futility stopping boundaries for binary endpoints;BMC Medical Research Methodology;2024-03-28

3. A Case Study of 2-Stage Seamless Adaptive Sample Size Re-Estimation Design with Efficacy Interim Analysis When Slope Is the Primary Endpoint;Statistics in Biopharmaceutical Research;2023-09-13

4. Left Upper Lobe Multi-Segmentectomy Versus Lobectomy for Early-Stage Lung Cancer: A Meta-Analysis;Heart, Lung and Circulation;2023-05

5. Some Multiplicity Adjustment Procedures for Clinical Trials with Sequential Design and Multiple Endpoints;Statistics in Biopharmaceutical Research;2023-04-14